Extrarenal potassium adaptation: the role of aldosterone

1989 ◽  
Vol 76 (2) ◽  
pp. 213-219 ◽  
Author(s):  
Aaron Spital ◽  
Richard H. Sterns

1. Prior adaptation to a high potassium (HK) diet reduces the increment in plasma potassium after nephrectomy and acute potassium loading. Previous work has suggested that this ‘extrarenal potassium adaptation’ is due to direct stimulation of cellular potassium uptake by chronic hyperaldosteronism. 2. In contrast, we have shown that when dietary potassium is withdrawn from HK rats, large urinary potassium losses persist, resulting in ‘paradoxical potassium depletion’. This potassium depletion facilitates cellular potassium uptake and is, at least in part, responsible for extrarenal potassium adaptation. 3. To try to reconcile these observations, we explored further the role of aldosterone in extrarenal potassium adaptation. When dietary potassium was withdrawn from chronically adrenalectomized HK rats, paradoxical potassium depletion was markedly blunted and extrarenal potassium adaptation could not be demonstrated. Similarly, urinary potassium losses and potassium depletion were reduced when acute adrenalectomy was performed concomitantly with dietary potassium withdrawal. 4. We were unable to confirm previous studies showing extrarenal potassium adaptation in the absence of potassium depletion. Thus, extrarenal potassium adaptation did not occur after pretreatment with chronic high-dose mineralocorticoid, after prior adaptation to a sodium-free diet, or after prior adaptation to an extremely HK diet in the absence of dietary potassium withdrawal. 5. We conclude that chronic hyperaldosteronism is important in extrarenal potassium adaptation, but probably not via direct enhancement of cellular potassium uptake. Rather, in HK animals, hyperaldosteronism magnifies urinary potassium losses during fasting and thus promotes potassium depletion, which in turn facilitates the uptake of an acute potassium load.

1984 ◽  
Vol 246 (3) ◽  
pp. F300-F308 ◽  
Author(s):  
W. R. Adam ◽  
G. J. Goland ◽  
R. M. Wellard

This study examines the role of adrenocortical hormones in the kaliuresis following an acute intragastric KCl load in conscious control (CK) and high potassium diet (HK) rats. Adrenalectomy, 1 day before test, reduced K+ excretion by 35% in CK and 60% in HK rats, leading to minimal differences in K excretion between CK and HK. By contrast, spironolactone inhibited K excretion by only 10%. Glucocorticoids (dexamethasone 3-10 micrograms/100 g) increased K+ excretion in adrenalectomized CK and to a greater extent in adrenalectomized HK rats. Aldosterone (3 micrograms/100 g) alone had a variable effect on urinary potassium excretion in adrenalectomized rats. A combination of dexamethasone (3 micrograms/100 g) and aldosterone (3 micrograms/100 g) in adrenalectomized rats induced potassium excretion equivalent to that in intact rats. Adrenalectomized HK rats had a greater kaliuretic response to dexamethasone and aldosterone than CK rats. These results 1) demonstrate a role for glucocorticoids in K+ excretion in HK rats and 2) illustrate the importance of the increased responsiveness to both glucocorticoids and mineralocorticoids in potassium adaptation.


1986 ◽  
Vol 251 (2) ◽  
pp. F199-F207
Author(s):  
S. K. Mujais ◽  
M. A. Chekal ◽  
J. P. Hayslett ◽  
A. I. Katz

The purpose of this study was to characterize the alterations in collecting tubule Na+-K+-ATPase activity produced by sustained increments in dietary potassium in the rat and to evaluate the role of aldosterone in their generation. In adrenal-intact animals, feeding a high-potassium diet (10-fold that of control) or administration of a high physiological dose of aldosterone (5 micrograms X 100 g-1 X day-1), which simulates the delivery rate of this hormone during potassium loading (both for 7 days), caused marked increments in Na+-K+-ATPase activity in the cortical collecting tubule (CCT) but had no effect on the enzyme in the inner stripe of the medullary collecting tubule (MCT). A significant increase in enzyme activity was also observed after smaller dietary potassium increments (2.5 and 5 times the control) and after 4 (but not 2) days of dietary potassium load. In adrenalectomized rats provided with physiological replacement doses of corticosterone and aldosterone (0.8 micrograms X 100 g-1 X day-1), Na+-K+-ATPase activity in both CCT and MCT was similar to that of adrenal-intact controls but remained unchanged after 7 days on the potassium-enriched (10-fold) diet. In contrast, adrenalectomized animals receiving the high physiological dose of aldosterone displayed an increase in Na+-K+-ATPase activity of CCT comparable with that of adrenal-intact animals, whereas the enzyme activity in the MCT was unaffected. In conclusion, 1) following chronic potassium loading Na+-K+-ATPase activity increases significantly in the CCT with no change in its activity in the inner stripe of the MCT.(ABSTRACT TRUNCATED AT 250 WORDS)


1985 ◽  
Vol 88 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Emily S. Foster ◽  
William J. Jones ◽  
John P. Hayslett ◽  
Henry J. Binder

1986 ◽  
Vol 251 (2) ◽  
pp. F313-F318 ◽  
Author(s):  
J. D. Blachley ◽  
B. P. Crider ◽  
J. H. Johnson

Following the ingestion of a high-potassium-content diet for only a few days, the plasma potassium of rats rises only modestly in response to a previously lethal dose of potassium salts. This acquired tolerance, termed potassium adaptation, is principally the result of increased capacity to excrete potassium into the urine. However, a substantial portion of the acute potassium dose is not immediately excreted and is apparently translocated into cells. Previous studies have failed to show an increase in the content of potassium of a variety of tissues from such animals. Using 86Rb as a potassium analogue, we have shown that the skeletal muscle of potassium-adapted rats takes up significantly greater amounts of potassium in vivo in response to an acute challenge than does that of control animals. Furthermore, the same animals exhibit greater efflux of 86Rb following the termination of the acute infusion. We have also shown that the Na+-K+-ATPase activity and ouabain-binding capacity of skeletal muscle microsomes are increased by the process of potassium adaptation. We conclude that skeletal muscle is an important participant in potassium adaptation and acts to temporarily buffer acute increases in the extracellular concentration of potassium.


1967 ◽  
Vol 47 (1) ◽  
pp. 39-46 ◽  
Author(s):  
V. V. E. St. Omer ◽  
W. K. Roberts

Balance studies were conducted with heifers weighing between 210–258 kg to determine effects of different dietary potassium levels, 156.6 (low), 439.4 (medium) and 1,086.8 (high) meq upon nutrient utilization. The low potassium ration produced an average negative potassium balance of 25.2 meq daily, while the other rations produced positive potassium balances. Urinary potassium excretion was markedly affected by potassium level while fecal potassium excretion was much less affected: in general, the higher the potassium intake, the higher the urinary and fecal potassium excretions. All heifers were in positive sodium balance and dietary level of potassium did not significantly influence either urinary or fecal excretion of sodium. Nitrogen balance was not significantly affected by treatment, but urinary ammonia excretion was significantly (P < 0.01) higher when the low potassium ration was fed. Water consumption and urine volume were significantly (P < 0.01) higher for the heifers fed high potassium, but water balance was not affected. Apparent digestibilities of energy, dry matter, nitrogen, crude fiber and ether extract were not significantly affected by treatment.Serum potassium levels were lower (P < 0.05) and phosphorus higher (P < 0.05) in heifers receiving the low than in heifers receiving the high level of potassium. Serum concentrations of sodium, chloride, calcium and magnesium were not significantly affected by dietary potassium.From the data, the potassium requirement for maintenance of the heifers was estimated to be 133 meq potassium daily per 100 kg body weight.


1983 ◽  
Vol 244 (4) ◽  
pp. F383-F391 ◽  
Author(s):  
S. Sastrasinh ◽  
R. L. Tannen

The influence on renal ammoniagenesis of a high potassium diet and also of acute manipulation of ambient potassium concentration was investigated using both the isolated perfused rat kidney and incubated renal cortical tubules. Ingestion of a high potassium diet for 1 wk resulted in potassium adaptation but had no effect on ammonia production by the isolated kidney perfused with physiologic concentrations of glutamine. By contrast, perfusion with a high ambient potassium concentration (8.0-9.3 mM) significantly increased renal tissue potassium levels and concomitantly reduced the rate of ammonia formation by 30% in comparison with perfusions at a normal potassium concentration. NH3 production by tubules incubated with 1 mM glutamine was also decreased at a K+ concentration of 9.0 mM. Ammonia production was unchanged when kidneys were perfused with a potassium concentration of 2.0 mM despite a 16% decrease in renal tissue potassium levels, but ammonia production by tubules incubated in 2 mM K+ was slightly less than in control incubations at 5.0 mM. Thus, unlike earlier in vitro studies with outer medullary slices, these studies do not support the hypothesis that an adaptive change in ammoniagenesis results from a high dietary potassium intake. However, a high ambient and renal intracellular potassium concentration can depress ammonia production. Although potassium depletion causes an adaptive increase in ammonia production, a decrease in ambient potassium concentration does not increase ammoniagenesis. Accordingly, both a potassium surfeit and deficit can modify renal ammonia production, but the mechanisms involved appear to differ.


Author(s):  
Rubina Yasmin ◽  
AKM Akhtaruzzaman ◽  
Paresh Chandra Sarker ◽  
Neaz Ahmed ◽  
Ranadhir Kumar Kundu ◽  
...  

This prospective clinical study was carried out in the Dept. of Anaesthesia, Analgesia and Intensive Care Medicine, BSMMU, Dhaka, during the period of May 2003 to July 2003. The study was done to emphasize the importance of giving analgesics preemptively instead of waiting for the child to complain of pain and to produce smooth recovery after surgery by decreasing immediate postoperative pain in children by a simple, safe acceptable drug. The children scheduled for tonsillectomy under general anaesthesia were recruited in this study. The analgesic efficiency of rectal paracetamol in two doses, 25 mg/kg bodywt.(Gr-P25) and 50 mg/kg. bodywt. (Gr-P50) were compared with Diclofenac Sodium suppository 1mg/ kg body weight (Gr-D) given half an hour before induction of anaesthesia. Pain scoring was done by TPPPS (Toddler Pre-schooler postoperative pain scale). Heart rate and blood pressure were stable in Gr-P50 and Gr-D. Time of first demand of analgesic was delayed in Gr-P50 and Gr-D. Total paracetamol consumption in 24 hours was less in Gr-P50(181±14.25) and Gr-D (212±25) than Gr-P25(318± 26.39). Total duration of analgesia in Gr- P50 (657±9.94) mins. and in Gr- D(502±10.63) mins. and in Gr-P25(288±23.17) mins. Pre-emptive high dose rectal paracetamol appears to be more effective than diclofenac sodium suppository for postoperative analgesia in children undergoing tonsillectomy. Journal of BSA, Vol. 18, No. 1 & 2, 2005 p.9-16


2021 ◽  
Vol 9 (3) ◽  
pp. 24
Author(s):  
Brian Heubel ◽  
Anja Nohe

The osteogenic effects of Bone Morphogenetic Proteins (BMPs) were delineated in 1965 when Urist et al. showed that BMPs could induce ectopic bone formation. In subsequent decades, the effects of BMPs on bone formation and maintenance were established. BMPs induce proliferation in osteoprogenitor cells and increase mineralization activity in osteoblasts. The role of BMPs in bone homeostasis and repair led to the approval of BMP2 by the Federal Drug Administration (FDA) for anterior lumbar interbody fusion (ALIF) to increase the bone formation in the treated area. However, the use of BMP2 for treatment of degenerative bone diseases such as osteoporosis is still uncertain as patients treated with BMP2 results in the stimulation of not only osteoblast mineralization, but also osteoclast absorption, leading to early bone graft subsidence. The increase in absorption activity is the result of direct stimulation of osteoclasts by BMP2 working synergistically with the RANK signaling pathway. The dual effect of BMPs on bone resorption and mineralization highlights the essential role of BMP-signaling in bone homeostasis, making it a putative therapeutic target for diseases like osteoporosis. Before the BMP pathway can be utilized in the treatment of osteoporosis a better understanding of how BMP-signaling regulates osteoclasts must be established.


2020 ◽  
Author(s):  
Shimpei Baba ◽  
Tohru Okanishi ◽  
Koichi Ohsugi ◽  
Rika Suzumura ◽  
Keiko Niimi ◽  
...  

AbstractWe describe the efficacy of high-dose barbiturates and early administration of a parenteral ketogenic diet (KD) as initial treatments for acute status epilepticus (SE) in an 8-year-old girl with febrile infection-related epilepsy syndrome (FIRES). The patient was admitted to our hospital with refractory focal SE. Abundant epileptic discharges over the left frontal region were observed on electroencephalogram (EEG). Treatment with continuous infusion of thiamylal for 4 hours, increased incrementally to 40 mg/kg/h, successfully ended the clinical SE, and induced a burst-suppression coma. The infusion rate was then gradually decreased to 4 mg/kg/h over the next 12 hours. Parenteral KD was administered from days 6 to 21 of illness. Continuous infusion of thiamylal was switched to midazolam on day 10 without causing seizures or EEG exacerbations. The patient has remained seizure free in the 15 months since hospital discharge. The effectiveness of KD for the treatment of FIRES has attracted attention amongst clinicians, but KD treatment may need to last for 2 to 4 days before it can stop SE, a time period that could cause irreversible brain damage. Considering the severity of SE in our patient and the dose of barbiturates needed to treat it, we consider this case to have had a good clinical outcome. The results suggest that rapid termination of seizure using high-dose barbiturates in conjunction with early administration of parenteral KD could reduce the development of chronic epilepsy in patients with FIRES.


Nanomaterials ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 743
Author(s):  
Marco Fidaleo ◽  
Stefano Tacconi ◽  
Carolina Sbarigia ◽  
Daniele Passeri ◽  
Marco Rossi ◽  
...  

Vitamin B12 (VitB12) is a naturally occurring compound produced by microorganisms and an essential nutrient for humans. Several papers highlight the role of VitB12 deficiency in bone and heart health, depression, memory performance, fertility, embryo development, and cancer, while VitB12 treatment is crucial for survival in inborn errors of VitB12 metabolism. VitB12 is administrated through intramuscular injection, thus impacting the patients’ lifestyle, although it is known that oral administration may meet the specific requirement even in the case of malabsorption. Furthermore, the high-dose injection of VitB12 does not ensure a constant dosage, while the oral route allows only 1.2% of the vitamin to be absorbed in human beings. Nanocarriers are promising nanotechnology that can enable therapies to be improved, reducing side effects. Today, nanocarrier strategies applied at VitB12 delivery are at the initial phase and aim to simplify administration, reduce costs, improve pharmacokinetics, and ameliorate the quality of patients’ lives. The safety of nanotechnologies is still under investigation and few treatments involving nanocarriers have been approved, so far. Here, we highlight the role of VitB12 in human metabolism and diseases, and the issues linked to its molecule properties, and discuss how nanocarriers can improve the therapy and supplementation of the vitamin and reduce possible side effects and limits.


Sign in / Sign up

Export Citation Format

Share Document